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Following the publication of the original article [1] it was 
brought to our attention that there are a number of major 
errors within the text which were not picked up upon by 
the authors until after publication.
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The authors accidentally copied the same pictures in 
Fig. 1d and Fig. 2d, Fig. 1g and Fig. 2g. The following are 
the correct pictures for Fig. 1d and g.
These changes won’t affect any of the figure legends 
and conclusions.
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Fig. 1 shRNA-mediated knockdown of oncogenic Kras reduces HK2 expression and suppresses growth in NSCLC cell lines. a, b Protein level of Kras 
and HK2 was detected in KP2 and H23 cells expressing shRNAs for Kras. c, d Clonogenic survival assays were performed to assess cell growth. Colo-
nies were stained by crystal violet after 7 days of cell growth. e, f Xenograft tumor growth. 1 × 106 cells expressing scramble shRNA (CON) or shRNA 
for Kras were subcutaneously injected to the lower flank of NSG mice. Representative images of tumors at 4 weeks after injection are shown (e). 
Quantification of tumors weight (P < 0.01) (f). g IHC staining of cell proliferation marker Ki67 from control or Kras-knockdown KP2 cells. h Quantifica-
tion of Ki67 expression from representative images shown in g (P < 0.01)
The online version of the original article can be found under 
doi:10.1186/s12935-016-0280-y.
